Labeler
Rising Pharma Holdings, Inc. NDC Codes
Rising Pharma Holdings, Inc. lists 529 finished drug products in the FDA NDC Directory under NDC labeler codes 16571, 57237, 64980.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Buspirone Hydrochloride, Memantine Hydrochloride, Albuterol Sulfate, Enalapril Maleate, Trazodone Hydrochloride, Spironolactone, Lorazepam, sumatriptan, Mexiletine Hydrochloride, Carbidopa and Levodopa, Timolol Maleate, Oxybutynin Chloride, azithromycin, Dimetane, Ranitidine
- Active ingredients
- Buspirone hydrochloride, Albuterol sulfate, Memantine hydrochloride, Enalapril maleate, Trazodone hydrochloride, Spironolactone, Lorazepam, Acetaminophen, Sumatriptan succinate, Cyclobenzaprine hydrochloride, Mexiletine hydrochloride, Carbidopa
- NDC labeler codes
- 16571, 57237, 64980
- Strengths (from the 100 most recently listed products)
- Guaifenesin 100 mg/5mL; Cetirizine hydrochloride 1 mg/mL; Levodopa 100 mg/1; Carbidopa 25 mg/1; Phenoxybenzamine hydrochloride 10 mg/1; Famotidine 40 mg/5mL; Oxybutynin chloride 2.5 mg/1; Azithromycin dihydrate 500 mg/1; Azithromycin dihydrate 250 mg/1; Esomeprazole magnesium 20 mg/1; Oxybutynin chloride 5 mg/1; Entacapone 200 mg/1; Sodium phosphate, Dibasic, Anhydrous 852 mg/1; Potassium phosphate, Monobasic 155 mg/1; Sodium phosphate, Monobasic, Monohydrate 130 mg/1; Clindamycin phosphate 10 mg/mL; Buspirone hydrochloride 5 mg/1; Buspirone hydrochloride 7.5 mg/1; Buspirone hydrochloride 10 mg/1; Buspirone hydrochloride 15 mg/1
- Dosage forms
- Tablet, Solution, Tablet, Film coated, Capsule, Cream, Capsule, Extended release, Tablet, Extended release, Suppository, Tablet, Delayed release, Tablet, Orally disintegrating, Capsule, Liquid filled, Liquid, Inhalant, Powder, For suspension, Capsule, Delayed release, Injection, Solution
- Routes
- Oral, Respiratory (Inhalation), Topical, Rectal, Ophthalmic, Intramuscular
- Drug classes (FDA established)
- Histamine-1 Receptor Antagonist, beta-Adrenergic Blocker, beta2-Adrenergic Agonist, Antiarrhythmic, N-methyl-D-aspartate Receptor Antagonist, Angiotensin Converting Enzyme Inhibitor, Serotonin Reuptake Inhibitor, Histamine-2 Receptor Antagonist, Proton Pump Inhibitor, Aldosterone Antagonist, Benzodiazepine, Anticholinergic, Serotonin-1b and Serotonin-1d Receptor Agonist, Central alpha-2 Adrenergic Agonist, Muscle Relaxant, Aromatic Amino Acid, Cholinergic Muscarinic Antagonist, Macrolide Antimicrobial, Expectorant, Azole Antifungal, Aminosalicylate, Non-Standardized Chemical Allergen, Monoamine Oxidase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Corticosteroid, Osmotic Laxative, Potassium Salt, Anti-coagulant, Calculi Dissolution Agent, alpha-Adrenergic Blocker, Catechol-O-Methyltransferase Inhibitor, Lincosamide Antibacterial, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Amide Local Anesthetic, Cephalosporin Antibacterial, Carbonic Anhydrase Inhibitor, Copper Absorption Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Central Nervous System Stimulant, Methylxanthine
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 180 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Pregabalin | Pregabalin 225 mg/1 | CapsuleOral | 64980-416 | 64980-0416-0164980-0416-0964980-0416-10 | — |
| Pregabalin | Pregabalin 300 mg/1 | CapsuleOral | 64980-417 | 64980-0417-0164980-0417-0964980-0417-10 | — |
| Pregabalin | Pregabalin 25 mg/1 | CapsuleOral | 64980-410 | 64980-0410-0164980-0410-0964980-0410-10 | — |
| Mesalamine | Mesalamine 1000 mg/1 | SuppositoryRectal | 64980-282 | 64980-0282-03 | — |
| Selegiline Hydrochloride | Selegiline hydrochloride 5 mg/1 | CapsuleOral | 16571-659 | 16571-0659-0616571-0659-50 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 64980-433 | 64980-0433-01 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 64980-434 | 64980-0434-01 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 64980-435 | 64980-0435-01 | — |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin b sulfates and hydrocortisone otic | Hydrocortisone 10 mg/mL + 2 more ingredients | SuspensionAuricular (Otic) | 64980-448 | 64980-0448-01 | — |
| Perphenazine | Perphenazine 2 mg/1 | Tablet, Film coatedOral | 64980-290 | 64980-0290-01 | — |
| Perphenazine | Perphenazine 4 mg/1 | Tablet, Film coatedOral | 64980-291 | 64980-0291-01 | — |
| Perphenazine | Perphenazine 8 mg/1 | Tablet, Film coatedOral | 64980-292 | 64980-0292-01 | — |
| Perphenazine | Perphenazine 16 mg/1 | Tablet, Film coatedOral | 64980-293 | 64980-0293-01 | — |
| Abiraterone acetate | Abiraterone acetate 250 mg/1 | TabletOral | 64980-418 | 64980-0418-12 | — |
| toremifene citrate | Toremifene citrate 60 mg/1 | TabletOral | 64980-404 | 64980-0404-03 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 2.5 mg/1 | Tablet, ChewableOral | 64980-221 | 64980-0221-01 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 5 mg/1 | Tablet, ChewableOral | 64980-222 | 64980-0222-01 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 10 mg/1 | Tablet, ChewableOral | 64980-223 | 64980-0223-01 | — |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | 64980-442 | 64980-0442-0164980-0442-50 | — |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | 64980-443 | 64980-0443-0164980-0443-50 | — |
| Abacavirabacavir sulfate | Abacavir sulfate 20 mg/mL | SolutionOral | 64980-405 | 64980-0405-24 | — |
| Lithium Carbonate | Lithium carbonate 450 mg/1 | Tablet, Extended releaseOral | 64980-278 | 64980-0278-01 | — |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | 64980-431 | 64980-0431-0164980-0431-1064980-0431-50 | — |
| Pyridostigmine Bromide | Pyridostigmine bromide 180 mg/1 | TabletOral | 64980-220 | 64980-0220-03 | — |
| Atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | 64980-373 | 64980-0373-03 | — |
| Atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | 64980-374 | 64980-0374-03 | — |
| Atomoxetine | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | 64980-375 | 64980-0375-03 | — |
| Atomoxetine | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | 64980-376 | 64980-0376-0364980-0376-10 | — |
| Atomoxetine | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | 64980-377 | 64980-0377-0364980-0377-10 | — |
| Atomoxetine | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | 64980-378 | 64980-0378-03 | — |
| Atomoxetine | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | 64980-379 | 64980-0379-03 | — |
| Chlorthalidone | Chlorthalidone 25 mg/1 | TabletOral | 64980-303 | 64980-0303-0164980-0303-10 | — |
| Chlorthalidone | Chlorthalidone 50 mg/1 | TabletOral | 64980-304 | 64980-0304-01 | — |
| Glipizide | Glipizide 2.5 mg/1 | Tablet, Film coated, Extended releaseOral | 64980-279 | 64980-0279-03 | — |
| Glipizide | Glipizide 5 mg/1 | Tablet, Film coated, Extended releaseOral | 64980-280 | 64980-0280-0164980-0280-0564980-0280-10 | — |
| Glipizide | Glipizide 10 mg/1 | Tablet, Film coated, Extended releaseOral | 64980-281 | 64980-0281-0164980-0281-0564980-0281-10 | — |
| Calcitriol | Calcitriol 1 ug/mL | SolutionOral | 64980-447 | 64980-0447-15 | — |
| Zileuton | Zileuton 600 mg/1 | Tablet, Extended releaseOral | 64980-206 | 64980-0206-12 | — |
| Diflorasone Diacetate | Diflorasone diacetate .5 mg/g | OintmentTopical | 64980-124 | 64980-0124-0364980-0124-1564980-0124-45+1 more | — |
| Lamivudine | Lamivudine 10 mg/mL | SolutionOral | 57237-274 | 57237-0274-24 | — |
| carisoprodol | Carisoprodol 250 mg/1 | TabletOral | 16571-780 | 16571-0780-01 | — |
| Erythromycin and Benzoyl Peroxide | Erythromycin 30 mg/g; Benzoyl peroxide 50 mg/g | GelTopical | 64980-328 | 64980-0328-0164980-0328-02 | — |
| Lansoprazole, Amoxicillin, Clarithromycin | — | Kit | 57237-001 | 57237-0001-14 | — |
| Oxybutynin Chloride Extended Releaseoxybutynin chloride | Oxybutynin chloride 5 mg/1 | Tablet, Extended releaseOral | 64980-209 | 64980-0209-0164980-0209-0364980-0209-05 | — |
| Oxybutynin Chloride Extended Releaseoxybutynin chloride | Oxybutynin chloride 10 mg/1 | Tablet, Extended releaseOral | 64980-210 | 64980-0210-0164980-0210-05 | — |
| Oxybutynin Chloride Extended Releaseoxybutynin chloride | Oxybutynin chloride 15 mg/1 | Tablet, Extended releaseOral | 64980-211 | 64980-0211-0164980-0211-05 | — |
| Darifenacin | Darifenacin hydrobromide 7.5 mg/1 | Tablet, Film coated, Extended releaseOral | 16571-767 | 16571-0767-0316571-0767-09 | — |
| Darifenacin | Darifenacin hydrobromide 15 mg/1 | Tablet, Film coated, Extended releaseOral | 16571-768 | 16571-0768-0316571-0768-09 | — |
| Fluocinolone Acetonide Oilfluocinolone acetonide | Fluocinolone acetonide .11 mg/mL | OilAuricular (Otic) | 64980-329 | 64980-0329-20 | — |
| Latanoprost | Latanoprost 50 ug/mL | SolutionOphthalmic | 64980-516 | 64980-0516-25 | — |
Rising Pharma Holdings, Inc.: common questions
- What is Rising Pharma Holdings, Inc.'s NDC labeler code?
- 16571, 57237, 64980. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Rising Pharma Holdings, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.